FDA Approved: CLOBETASOL PROPIONATE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approves a supplemental application for clobetasol propionate from Actavis Pharma, Inc. to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Dermatitis
• Lichen Simplex Chronicus
• Plaque Psoriasis

Drugs mentioned

• CLOBETASOL PROPIONATE (Clobetasol propionate)

Snippet

SUPPL AP for CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)